Diastat and Lacrimal disorder - a phase IV clinical study of FDA data
We study 2,516 people who take Diastat or have Lacrimal disorder. No report of Lacrimal disorder is found in people who take Diastat.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Diastat?
Diastat has active ingredients of diazepam. eHealthMe is studying from 1,791 Diastat users for its effectiveness, alternative drugs and more.
What is Lacrimal Disorder?
Lacrimal disorder (disease of lacrimal duct) is found to be associated with 671 drugs and 358 conditions by eHealthMe.
Do you take Diastat and have Lacrimal disorder?Check whether Lacrimal disorder is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Lacrimal disorder and when was it recovered:
Expand to all the drugs that have ingredients of diazepam:
Alternative drugs to, pros and cons of Diastat:
- Diastat (1,791 reports)
Lacrimal disorder treatments and more:
- Lacrimal disorder (725 reports)
COVID vaccines that are related to Lacrimal disorder:
- Lacrimal disorder in Moderna COVID Vaccine
- Lacrimal disorder in Pfizer BioNTech Covid Vaccine
- Lacrimal disorder in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Lacrimal disorder:
All the conditions that are associated with Lacrimal disorder:
How the study uses the data?
The study uses data from the FDA. It is based on diazepam (the active ingredients of Diastat) and Diastat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lupron and Tylenol W/ Codeine No. 3 drug interaction - 2 seconds ago
- How effective is Paxil Cr for Major Depression? - 6 seconds ago
- Oxycodone and Lower Respiratory Tract Infection Bacterial - 7 seconds ago
- Zykadia and Weakness - 8 seconds ago
- Sildenafil Citrate and Renal Impairment - 11 seconds ago
- Zoloft and Aczone drug interaction - 18 seconds ago
- Alvesco and Vyvanse drug interaction - 18 seconds ago
- Celebrex and Pelvic Abscess - 24 seconds ago
- Benicar and Varicose Vein - 25 seconds ago
- Nuvigil and Vasculitis - 29 seconds ago